<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04429178</url>
  </required_header>
  <id_info>
    <org_study_id>2020-00774; qu19Buddeberg</org_study_id>
    <nct_id>NCT04429178</nct_id>
  </id_info>
  <brief_title>Portal Vein Pulsatility Flow in Pregnancy</brief_title>
  <official_title>Portal Vein Pulsatility Flow in Pregnancy - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate if portal vein pulsatility fraction can be measured in pregnancy&#xD;
      and if it increases during the course of pregnancy as would be expected by the physiologic&#xD;
      increase in blood volume that happens during pregnancy. Portal vein pulsatility fraction is&#xD;
      measured in non-pregnant controls and in women in the 1st, 2nd and 3rd trimester of&#xD;
      pregnancy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 13, 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Portal vein pulsatility fraction (percent)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Portal vein pulsatility fraction (percent)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inferior vena cava diameter (mm)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Inferior vena cava diameter (mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inferior vena cava collapsibility index (percent)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Inferior vena cava collapsibility index (percent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatic venous flow (cm/sec)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Hepatic venous flow (cm/sec)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right atrial and ventricular dimensions (cm)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Right atrial and ventricular dimensions (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tricuspid Annular Plane Systolic Excursion (TAPSE) (mm)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Tricuspid Annular Plane Systolic Excursion (TAPSE) (mm)</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>women in the 1st trimester of pregnancy.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>women in the 2nd trimester of pregnancy.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>women in the 3rd trimester of pregnancy.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-pregnant women</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ultrasound</intervention_name>
    <description>portal vein pulsatility fraction (percent) measured with ultrasound</description>
    <arm_group_label>non-pregnant women</arm_group_label>
    <arm_group_label>women in the 1st trimester of pregnancy.</arm_group_label>
    <arm_group_label>women in the 2nd trimester of pregnancy.</arm_group_label>
    <arm_group_label>women in the 3rd trimester of pregnancy.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women attending either the anaesthetic preassessment clinic or the obstetric&#xD;
        ultrasound clinic at University Hospital Basel.&#xD;
&#xD;
        Non-pregnant healthy females fulfilling the inclusion criteria will be recruited by&#xD;
        published advertisement at the University Hospital Basel.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ability to give informed consent&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) Class I and II&#xD;
&#xD;
          -  Singleton pregnancy during 1st, 2nd or 3rd trimester or healthy non-pregnant females&#xD;
             of childbearing age as controls&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to give informed consent&#xD;
&#xD;
          -  Multiple gestation&#xD;
&#xD;
          -  Significant co-morbidities (e.g. cardiac abnormalities, cardiac dysfunction,&#xD;
             arrhythmias, severe asthma, renal insufficiency)&#xD;
&#xD;
          -  High risk pregnancies (e.g. pre-eclampsia, gestational hypertension, HELLP,&#xD;
             gestational diabetes)&#xD;
&#xD;
          -  Body-Mass-Index (BMI) &lt; 18kg/m2 or &gt;40kg/m2&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bigna Buddeberg, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, University Hospital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bigna Buddeberg, Dr. med.</last_name>
    <phone>+41 61 328 6417</phone>
    <email>bigna.buddeberg@usb.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology, University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bigna Buddeberg, Dr. med.</last_name>
      <phone>+41 61 328 6417</phone>
      <email>bigna.buddeberg@usb.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 9, 2020</study_first_submitted>
  <study_first_submitted_qc>June 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2020</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>portal vein pulsatility</keyword>
  <keyword>physiologic volume overload</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

